Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
In one of the first clinical trials intended to compare the standard of care for diabetic foot wounds against EpiFix, a dehydrated human amnion/chorion membrane allograft (dHACM), researchers…
In June of 2015, the Nassau Inn of Princeton, New Jersey played host to a conference focusing on the adoption and execution of mobile strategies within pharmaceutical companies.…
Each week The Doctor's Channel and IMS Health's Appscript.net present you with a useful and thoughtfully designed app that can help both patients and their physicians with health-related…
With a multitude of glucose meters on the market, it can sometimes be difficult for endocrinologists to maintain the inventory of software and cables necessary to access all…
CardioMEMS is a cardiac monitoring system from St. Jude Medical that has been proven to reduce heart failure hospital admissions by NYHA Class III patients.
Researchers have developed a way to communicate with human neurons through biochemical interactions, taking neurological medicine beyond the current limits of electrical impulse communication.
Each week, The Doctor's Channel and IMS Health's Appscript.net present you with a useful and thoughtfully designed app that can help both patients and their physicians with health-related…
